Cyprodenate
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.025 |
Chemical and physical data | |
Formula | C13H25NO2 |
Molar mass | 227.34 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
See also
References
- Dormard Y, Levron JC, Le Fur JM (February 1975). "Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals". Arzneimittel-Forschung. 25 (2): 201–7. PMID 1173033.
- Bobkov I, Morozov IS (October 1982). "[Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 94 (10): 48–51. doi:10.1007/BF00827201. PMID 6129008. S2CID 19153614.
DRAs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.